Brokerages Set Owens & Minor, Inc. (NYSE:OMI) PT at $18.50

Shares of Owens & Minor, Inc. (NYSE:OMI) have earned a consensus rating of “Hold” from the eight brokerages that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $16.79.

A number of brokerages recently commented on OMI. Citigroup decreased their target price on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Barclays decreased their target price on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. Robert W. Baird decreased their target price on shares of Owens & Minor from $15.00 to $14.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 4th. Finally, UBS Group decreased their price objective on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Thursday.

Insider Buying and Selling at Owens & Minor

In other news, CFO Jonathan A. Leon sold 5,282 shares of Owens & Minor stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $11.82, for a total transaction of $62,433.24. Following the sale, the chief financial officer now owns 130,822 shares of the company’s stock, valued at approximately $1,546,316.04. The trade was a 3.88 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 3.59% of the company’s stock.

Institutional Investors Weigh In On Owens & Minor

Large investors have recently modified their holdings of the stock. Royce & Associates LP boosted its stake in shares of Owens & Minor by 179.4% during the 3rd quarter. Royce & Associates LP now owns 80,914 shares of the company’s stock valued at $1,270,000 after purchasing an additional 51,955 shares in the last quarter. FMR LLC boosted its stake in Owens & Minor by 0.8% during the third quarter. FMR LLC now owns 11,564,624 shares of the company’s stock worth $181,449,000 after acquiring an additional 90,862 shares in the last quarter. Waldron Private Wealth LLC bought a new stake in Owens & Minor during the fourth quarter worth about $406,000. JPMorgan Chase & Co. boosted its stake in Owens & Minor by 68.4% during the third quarter. JPMorgan Chase & Co. now owns 376,830 shares of the company’s stock worth $5,912,000 after acquiring an additional 152,999 shares in the last quarter. Finally, Foundry Partners LLC bought a new stake in Owens & Minor during the third quarter worth about $5,238,000. Institutional investors own 98.04% of the company’s stock.

Owens & Minor Price Performance

Shares of NYSE:OMI opened at $7.45 on Friday. The stock has a market cap of $574.08 million, a PE ratio of -11.45, a PEG ratio of 0.25 and a beta of 0.48. The company’s fifty day moving average is $12.80 and its 200 day moving average is $13.84. Owens & Minor has a 52 week low of $7.41 and a 52 week high of $28.35. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.